CRYO-CELL INTERNATIONAL, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $507.30 thousand as of 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-07-15
- 2026-05-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $507.30K.
- 2026-02-28: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $249.67K.
- 2025-11-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $319.03K.
- 2025-08-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $265.21K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2026-05-31 | $507.30K 10-Q · filed 2026-07-15 |
| 2026-02-28 | $249.67K 10-Q · filed 2026-04-14 |
| 2025-11-30 | $319.03K 10-Q · filed 2026-07-15 |
| 2025-08-31 | $265.21K 10-Q · filed 2025-10-15 |
| 2025-05-31 | $137.49K 10-Q · filed 2026-07-15 |
| 2025-02-28 | $223.12K 10-Q · filed 2026-04-14 |
| 2024-11-30 | $560.96K 10-Q · filed 2026-07-15 |
| 2024-08-31 | $197.44K 10-Q · filed 2025-10-15 |
| 2024-05-31 | $469.19K 10-Q · filed 2025-07-15 |
| 2024-02-29 | $247.11K 10-Q · filed 2025-04-14 |
| 2023-11-30 | $406.07K 10-K · filed 2026-02-27 |
| 2023-08-31 | $584.00K 10-Q · filed 2024-10-15 |
| 2023-05-31 | $1.12M 10-Q · filed 2024-07-15 |
| 2023-02-28 | $1.37M 10-Q · filed 2024-04-15 |
| 2022-11-30 | $1.70M 10-K · filed 2025-02-28 |
| 2022-08-31 | $2.92M 10-Q · filed 2023-10-12 |
| 2022-05-31 | $2.80M 10-Q · filed 2023-07-14 |
| 2022-02-28 | $2.14M 10-Q · filed 2023-04-21 |
| 2021-11-30 | $8.26M 10-K · filed 2024-02-28 |
| 2021-08-31 | $7.70M 10-Q · filed 2022-10-18 |
| 2021-05-31 | $7.95M 10-Q · filed 2022-07-11 |
| 2020-11-30 | $10.36M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |